626 E Whispering Oaks, Palatine, IL 60074
+1-224-678-1803 info@7newswire.com Book A Demo

Inari Medical, Inc. Sued for Securities Law Violations - Investors With Losses in Excess of $100K Should Contact The Rosen Law Firm Before July 12, 2024 to Discuss Your Rights - NARI

7Newswire

NEW YORKJuly 7, 2024 /7Newswire

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inari Medical, Inc. (NASDAQ: NARI) between February 24, 2022 and February 28, 2024, both dates inclusive (the “Class Period”), of the important July 12, 2024 lead plaintiff deadline.

So what: If you purchased Inari Medical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Inari Medical class action, go to https://rosenlegal.com/submit-form/?case_id=22855 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 12, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Details of the case: According to the lawsuit, defendants throughout the Class Period touted Inari’s “record revenue,” purportedly driven by “the strength in our core [venous thromboembolism] (“VTE”) business.” But defendants failed to disclose that a significant portion of its expenses were used to compensate medical professionals improperly for using Inari’s products. In truth, while defendants were speaking positively about Inari Medical’s growth prospects, it had been engaging in illegal business practices. Specifically, Inari Medical had been unlawfully compensating health care professionals in violation of the federal Anti-Kickback Statute and Civil False Claims Act. Defendants also misled investors regarding business expenses in order to conceal their illicit conduct. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Inari Medical class action, go to https://rosenlegal.com/submit-form/?case_id=22855 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      case@rosenlegal.com
      www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.